SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-24-013723
Filing Date
2024-04-29
Accepted
2024-04-29 16:37:21
Documents
5
Period of Report
2024-06-11

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A vxrt20240423_def14a.htm DEF 14A 1141485
2 capni.jpg GRAPHIC 26311
3 captsr.jpg GRAPHIC 29172
4 proxy_page1.jpg GRAPHIC 196069
5 proxy_page2.jpg GRAPHIC 139148
  Complete submission text file 0001437749-24-013723.txt   1681113
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35285 | Film No.: 24891800
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)